We are live on ! Find out more
ERIC

Eagle Rock Investment Company Portfolio holdings

AUM $808M
1-Year Est. Return 44.28%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+44.28%
3 Year Est. Return
+115.35%
5 Year Est. Return
10 Year Est. Return
AUM
$602M
AUM Growth
+$4.85M
Cap. Flow
-$1.12M
Cap. Flow %
-0.19%
Top 10 Hldgs %
37.8%
Holding
159
New
4
Increased
43
Reduced
54
Closed
8

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$2.43M
2
V icon
Visa
V
+$2.4M
3
GEHC icon
GE HealthCare
GEHC
+$2.2M
4
AMAT icon
Applied Materials
AMAT
+$1.83M
5
TTWO icon
Take-Two Interactive
TTWO
+$1.64M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.46M
2
AVGO icon
Broadcom
AVGO
+$3.53M
3
ELV icon
Elevance Health
ELV
+$2.99M
4
HAS icon
Hasbro
HAS
+$2.34M
5
KHC icon
Kraft Heinz
KHC
+$1.47M

Sector Composition

Rank Sector Weight
1 Technology 24.6%
2 Financials 16.21%
3 Communication Services 12.03%
4 Healthcare 10.4%
5 Consumer Discretionary 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
76
ConocoPhillips
COP
$151B
$1.9M 0.32%
19,160
CNQ icon
77
Canadian Natural Resources
CNQ
$98.3B
$1.89M 0.31%
61,351
+555
+0.9% +$18.7K
AMGN icon
78
Amgen
AMGN
$225B
$1.8M 0.3%
6,897
AMAT icon
79
Applied Materials
AMAT
$434B
$1.64M 0.27%
+10,092
New +$1.83M
CME icon
80
CME Group
CME
$93.8B
$1.64M 0.27%
7,050
-2,765
-28% -$636K
TFI icon
81
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.17B
$1.61M 0.27%
35,257
+130
+0.4% +$6K
LMT icon
82
Lockheed Martin
LMT
$138B
$1.58M 0.26%
3,256
-3
-0.1% -$1.64K
SYK icon
83
Stryker
SYK
$131B
$1.56M 0.26%
4,328
SO icon
84
Southern Company
SO
$106B
$1.53M 0.25%
18,534
-185
-1% -$16.2K
SCHW
85
Charles Schwab
SCHW
$187B
$1.5M 0.25%
20,279
CTRA
86
DELISTED
Coterra Energy
CTRA
$1.41M 0.23%
55,195
FWONK icon
87
Liberty Media Series C
FWONK
$26.2B
$1.34M 0.22%
14,430
USFD icon
88
US Foods
USFD
$23.4B
$1.33M 0.22%
+19,645
New +$1.29M
ETN icon
89
Eaton
ETN
$180B
$1.31M 0.22%
3,950
BMY icon
90
Bristol-Myers Squibb
BMY
$130B
$1.18M 0.2%
20,824
-23,364
-53% -$1.31M
SKX
91
DELISTED
Skechers
SKX
$1.15M 0.19%
17,103
BAH icon
92
Booz Allen Hamilton
BAH
$9.26B
$1.15M 0.19%
8,900
ABBV icon
93
AbbVie
ABBV
$441B
$1.01M 0.17%
5,683
-189
-3% -$34.7K
HAS icon
94
Hasbro
HAS
$13.5B
$985K 0.16%
17,624
-35,785
-67% -$2.34M
WEX icon
95
WEX
WEX
$6.42B
$918K 0.15%
+5,234
New +$981K
ACN icon
96
Accenture
ACN
$108B
$901K 0.15%
2,561
-63
-2% -$22.7K
WMT icon
97
Walmart Inc
WMT
$913B
$894K 0.15%
9,895
-3,174
-24% -$275K
GILD icon
98
Gilead Sciences
GILD
$169B
$891K 0.15%
9,649
J icon
99
Jacobs Solutions
J
$16.9B
$887K 0.15%
6,705
EFA icon
100
iShares MSCI EAFE ETF
EFA
$80.2B
$862K 0.14%
11,394
-2,262
-17% -$179K

Similar funds

Eagle Rock Investment Company's Q4 2024 Portfolio in Review

As of Q4 2024, Eagle Rock Investment Company held 159 positions worth $602M, up 0.81% from $597M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Eagle Rock Investment Company's Q4 2024 filing shows 4 new, 43 increased, 54 reduced and 8 closed positions. Its largest new stake was Applied Materials: 10,092 shares worth $1.64M. The largest sale was Pfizer, an estimated $4.46M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

  • Eagle Rock Investment Company's largest Q4 2024 buy was Applied Materials: 10,092 shares worth $1.64M.
  • Eagle Rock Investment Company added most to HCA Healthcare in Q4 2024, an estimated $2.43M increase.
  • Eagle Rock Investment Company's biggest Q4 2024 reduction was Pfizer, cutting an estimated $4.46M.
  • Eagle Rock Investment Company fully exited Rio Tinto in Q4 2024, selling an estimated $1.1M.
  • Eagle Rock Investment Company's ten largest holdings make up 38% of its $602M portfolio in Q4 2024.
  • Eagle Rock Investment Company opened 4 new positions and closed 8 in Q4 2024.
  • Eagle Rock Investment Company's portfolio value rose 0.81% quarter-over-quarter to $602M.

Based on Eagle Rock Investment Company's 13F filing for Q4 2024, filed 15 Jan 2025.